News

Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees, nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential.
Find Vaccine Experts Latest News, Videos & Pictures on Vaccine Experts and see latest updates, news, information from NDTV.COM. Explore more on Vaccine Experts.